The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
Open accessAbstract
with ABT-263 (navitoclax) effectively treats established fibrosis in a mouse model of scleroderma dermal fibrosis by inducing myofibroblast apoptosis. Using a BH3 profiling assay to assess mitochondrial priming in dermal fibroblasts derived from patients with scleroderma, we demonstrate that the extent of apoptosis induced by BH3 mimetic drugs correlates with the extent of their mitochondrial priming, indicating that BH3 profiling could predict apoptotic responses of fibroblasts to BH3 mimetic drugs in patients with scleroderma. Together, our findings elucidate the potential efficacy of targeting myofibroblast antiapoptotic proteins with BH3 mimetic drugs in scleroderma and other fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This increased stiffness is an important survival signal for myofibroblasts; via mechanosensing such stiffness results in intracellular activation of Rho and Rho-associated kinase (ROCK) whose activity increases BCL2-XL expression (36).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [36]
In the citing paper
“Recently, it has been shown that pharmacological inhibition of BCL2-XL can mimic this process and induce targeted BIM-mediated apoptosis in myofibroblasts and even revert established (murine) fibrosis (36).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [36]
In the citing paper
“Importantly, this increased, stiffness-induced, BCL2-XL expression is needed to counteract the function of the pro-apoptotic protein BIM (36). BIM is an activator of BAX and accumulates in myofibroblasts exposed to a stiff matrix. This accumulation primes the cells to undergo apoptosis (36), and only the continued presence of BCL2-XL prevents this.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,806
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407
Self-citationControl of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 246
Gu, X., Meng, H., Peng, C., Lin, S., Li, B., Zhao, L., Yang, X., Wang, G., Cai, W., Zhou, J., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1308 · Cited by 23
Assessing the progression of systemic sclerosis by monitoring the tissue optic axis using PS-OCT
Adams, D. C., Szabari, M. V., Lagares, D., McCrossan, A. F., Hariri, L. P., Tager, A. M., & Suter, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-59330-7 · Cited by 24
Self-citationBerberich, B., Thriene, K., Gretzmeier, C., Kühl, T., Bayer, H., Athanasiou, I., Rafei-Shamsabadi, D. A., Bruckner‐Tuderman, L., Nyström, A., Kiritsi, D., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.02.040 · Cited by 26
Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategies
Asano, Y., & Varga, J. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.12.007 · Cited by 24
Regulation of Fibroblast Apoptosis and Proliferation by Micro RNA ‐125b in Systemic Sclerosis
Kozlova, A., Pachera, E., Maurer, B., Jüngel, A., Distler, J. H. W., Kania, G., & Distler, O. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41041 · Cited by 22
Nho, R. S., Rice, C., Prasad, J. M. N., Bone, H., Farkas, L., Rojas, M. M., & Horowitz, J. C. (2023) · Physiological Reports · doi:10.14814/phy2.15759 · Cited by 23
Corallo, C., Cheleschi, S., Cutolo, M., Soldano, S., Fioravanti, A., Volpi, N., Franci, D., Nuti, R., & Giordano, N. G. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1931-x · Cited by 22
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting
Romano, E., Rosa, I., Fioretto, B. S., Matucci‐Cerinic, M., & Manetti, M. (2021) · Current Molecular Medicine · doi:10.2174/0929867328666210325102749 · Cited by 24
Targeting the BCL2 Family: Advances and Challenges in BH3 Mimetic-Based Therapies
Mukherjee, N., Sheetz, J., & Shellman, Y. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209859 · Cited by 24
Bonneaud, T. L., Lefebvre, C. C., Nocquet, L., Basseville, A., Roul, J., Weber, H., Campone, M., Juin, P. P., & Souazé, F. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05214-9 · Cited by 23
Ohta, S., Matsuura, M., Kawashima, Y., Cai, X., Taniguchi, M., Okochi, H., Asano, Y., Sato, S., & Ito, T. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.028 · Cited by 18
Blake, R. R., Markby, G. R., Culshaw, G., Pereira, Y. M., Lu, C.-C., & CORCORAN, B. M. (2019) · Research in Veterinary Science · doi:10.1016/j.rvsc.2019.11.004 · Cited by 18
How to Keep Myofibroblasts under Control: Culture of Mouse Skin Fibroblasts on Soft Substrates
Son, D. O., Benítez, R., Diao, L., & Hinz, B. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.05.033 · Cited by 18
Huang, Z., Liao, Y., Zheng, Y., Ye, S., Zhang, Q., Yu, X., Liu, X., & Li, N. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04306-1 · Cited by 19
RetractedMitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis
Kim, S., Lee, J. Y., Yoon, C. M., Shin, H. J., Lee, S. W., Rosas, I. O., Herzog, E. L., Cruz, C. S. D., Kaminski, N., & Kang, M. (2020) · European Respiratory Journal · doi:10.1183/13993003.00652-2020 · Cited by 18
Extracellular Targets to Reduce Excessive Scarring in Response to Tissue Injury
Fertala, J., Wang, M. L., Rivlin, M. R., Beredjiklian, P. K., Abboud, J. A., Arnold, W. V., & Fertala, A. (2023) · Biomolecules · doi:10.3390/biom13050758 · Cited by 18
BCL-2 Modulates IRE1α Activation to Attenuate Endoplasmic Reticulum Stress and Pulmonary Fibrosis
Saux, C. J. L., Ho, T. C., Brumwell, A. M., Kathiriya, J. J., Wei, Y. J., Hughes, J. B., Garakani, K., Atabai, K., Auyeung, V. C., Papa, F. R., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0109oc · Cited by 16
Novel role of long non-coding RNAs in autoimmune cutaneous disease
Muntyanu, A., Le, M., Ridha, Z., O’Brien, E. A., Litvinov, I. V., Lefrançois, P., & Netchiporouk, E. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00639-x · Cited by 16
Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis
Singh, M., Sarhan, M. O., Damiba, N. N. L., Singh, A., Villabona-Rueda, A. F., Nino-Meza, O. J., Chen, X., Masias-Leon, Y., Ruiz-Gonzalez, C. E., Ordoñez, A. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58190-x · Cited by 17
Fibroblasts as regulators of lung immunity, repair and fibrosis
Bell, P. T., & Belz, G. T. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01268-4 · Cited by 19
Kerick, M., González‐Serna, D., Carnero‐Montoro, E., Teruel, M., Acosta‐Herrera, M., Makowska, Z., Buttgereit, A., Babaei, S., Barturen, G., López‐Isac, E., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41657 · Cited by 14
The senolytic drug ABT-263 accelerates ovarian aging in older female mice
Xia, X., Yang, Y., Liu, P., Chen, L., Dai, X., Xue, P., & Wang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-73828-4 · Cited by 15
Mechanosensing regulates pDC activation in the skin through NRF2 activation
Chaudhary, V., Mishra, B., Kioon, M. D. A., Du, Y., Ivashkiv, L. B., Crow, M. K., & Barrat, F. J. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20240852 · Cited by 15
Hussain, S. S., George, S., Singh, M., Jayant, R. D., Hu, C.-A. A., Sopori, M. L., & Chand, H. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-32114-w · Cited by 14
Sapao, P., Roberson, E. D. O., Shi, B., Assassi, S., Skaug, B. A., Lee, F., Naba, A., White, B. E. P., Córdova-Fletes, C., Tsou, P., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.08.052 · Cited by 14
Self-citationJiang, W., Pang, X., Ha, P., Li, C., Chang, G. X., Zhang, Y., Bossong, L. A., Ting, K., Soo, C. B., & Zheng, Z. S. (2025) · Nature Communications · doi:10.1038/s41467-025-58906-z · Cited by 13
Mechanical stiffness promotes skin fibrosis through FAPα-AKT signaling pathway
He, J., Fang, B., Shan, S., & Li, Q. (2023) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2023.12.004 · Cited by 13
Kim, E., Kim, H. K., Sul, J. H., Lee, J., Baek, S. H., Cho, Y., Han, J., Kim, J., Park, S., Park, J. H., et al. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.191 · Cited by 13
Johnson, L. A., Rodansky, E. S., Tran, A., Collins, S., Eaton, K. A., Malamet, B. J., Steiner, C. A., Huang, S., Spence, J. R., & Higgins, P. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab166 · Cited by 13
The pathophysiology and treatment of musculoskeletal fibrosis
Sheets, K., Overbey, J., Ksajikian, A., Bovid, K. M., Kenter, K., & Li, Y. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30217 · Cited by 14
Jeong, H. Y., Park, J., Choi, J. W., Lee, K. H., Yang, S. C., Kang, H. Y., Cho, S., Lee, S.-Y., Lee, A. R., Park, Y., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01366-0 · Cited by 13
Anti-aging therapy for pulmonary fibrosis
Zhou, Y., & Lagares, D. (2021) · Nature Aging · doi:10.1038/s43587-021-00035-5 · Cited by 13
Self-citationSpina, J. S., Carr, T. L., Phillips, L. A., Knight, H., Crosbie, N. E., Lloyd, S. M., Jhala, M. A., Lam, T. J., Kármán, J., Clements, M. E., et al. (2024) · Aging · doi:10.18632/aging.205994 · Cited by 12
MEOX1 triggers myofibroblast apoptosis resistance, contributing to pulmonary fibrosis in mice
Jin, L., Bao, B., Huang, X., Tao, J., Duan, J., Zhong, W., Zhang, C., Liu, Y., Chen, H., Yang, N., et al. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31442 · Cited by 11
Tension-induced organelle stress: an emerging target in fibrosis
Kai, F., Leidal, A. M., & Weaver, V. M. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.12.006 · Cited by 11
Zhou, Y., Zhang, Y., Cheng, H., Li, X., Feng, D., Yue, S., Xu, J., Xie, H., & Luo, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10112715 · Cited by 10
Regulation of cardiac fibroblast cell death by unfolded protein response signaling
Rowland, M. B., Moore, P. E., & Correll, R. N. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1304669 · Cited by 10
Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B
Flaxman, H. A., Chrysovergi, M.-A., Han, H., Kabir, F., Lister, R. T., Chang, C., Yvon, R., Black, K. E., Weigert, A., Savai, R., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.171162 · Cited by 13
Self-citationA novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
Zhao, T., He, Q., Xie, S., Zhan, H., Jiang, C., Lin, S., Liu, F., Wang, C., Chen, G., & Zeng, H. (2023) · Molecular Medicine · doi:10.1186/s10020-022-00565-7 · Cited by 10
Self-citationSarkar, A., Das, S., Bone, H., DeVengencie, I., Prasad, J. M. N., Farkas, D., Londino, J. D., Nho, R. S., Rojas, M. M., & Horowitz, J. C. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200511 · Cited by 10
Liu, L., Sun, Y., Zhao, Y., Wang, Q., Guo, H. B., Guo, R., Liu, Y., Fu, S., Zhang, L., Li, Y., et al. (2018) · Cancer Science · doi:10.1111/cas.13825 · Cited by 10
The Importance of Cancer-Associated Fibroblasts in the Pathogenesis of Head and Neck Cancers
Raudenská, M., Svobodová, M., Gumulec, J., Falk, M., & Masařík, M. (2020) · Klinicka onkologie · doi:10.14735/amko202039 · Cited by 10
Nguyen, M. T., Lee, M.-A., Kim, Y., Kook, H., Jeong, D., Jang, S. P., Kwak, T. H., & Park, W. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269735 · Cited by 10
Melanocortin therapies to resolve fibroblast-mediated diseases
Khodeneva, N., Sugimoto, M. A., Davan-Wetton, C. S. A., & Montero‐Melendez, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1084394 · Cited by 10
m6A modification in non-coding RNAs: Mechanisms and potential therapeutic implications in fibrosis
Zhou, Y., Jian, N., Jiang, C., & Wang, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117331 · Cited by 11
Towards a Unified Approach in Autoimmune Fibrotic Signalling Pathways
Sisto, M., & Lisi, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109060 · Cited by 9
Jiao, F., Andrianov, A. M., Wang, L., Furs, K. V., Gonchar, A. V., Wang, Q., Xu, W., Lu, L., Xia, S., Tuzikov, A. V., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29145 · Cited by 9
M. S. Barron, A., Fabre, T., & De, S. (2024) · F1000Research · doi:10.12688/f1000research.143472.1 · Cited by 8
Dworak, H., Rozmaric, T., Grillari, J., & Ogrodnik, M. B. (2025) · FEBS Letters · doi:10.1002/1873-3468.70037 · Cited by 8
Pathophysiology in Systemic Sclerosis: Current Insights and Future Perspectives
Al-Gburi, S., Moinzadeh, P., & Krieg, T. (2025) · Sclerosis · doi:10.3390/sclerosis3020017 · Cited by 8
The Role of Autophagy and Apoptosis in Affected Skin and Lungs in Patients with Systemic Sclerosis
Spasovski, V., Andjelković, M., Parezanovic, M., Komazec, J., Ugrin, M., Klaassen, K., & Stojiljković, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311212 · Cited by 8
Li, S., Wang, Y., Chen, Y., Zhang, H., Shen, K., & Guan, H. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109912 · Cited by 8
Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine
Jeong, M. H., Han, H., Lagares, D., & Im, H. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00028 · Cited by 10
Self-citationDesmoulière, A., & Hinz, B. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12942 · Cited by 9
Reimagining Fibrosis Research, Outcomes, and Therapeutics Through the Lens of Resolution
Fortier, S. M., Redente, E. F., & Peters-Golden, M. L. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2666-7479 · Cited by 7
Integrating Senescence and Oxidative Stress in Cardiac Disease
Yun, H. R., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Kim, S. S., & Kang, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411917 · Cited by 8
Proinflammatory cytokines sensitise mesenchymal stromal cells to apoptosis
Payne, N. L., Pang, S. H. M., Freeman, A. J., Ozkocak, D. C., Limar, J. W., Wallis, G., Zheng, D., Mendonca, S., O’Reilly, L. A., Gray, D. H. D., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02412-0 · Cited by 7
Hippo signaling in mechanobiology: Mechanical control of YAP/TAZ and their roles in disease
Kim, Y., Lee, H., Lee, J.-H., Kim, W., & Cha, B. (2026) · Mechanobiology · doi:10.1177/29780241261430920 · Cited by 7
Negi, V., Singh, P. K., Singh, L., Pandey, R. K., & Kumar, S. (2023) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265262440231103094609 · Cited by 6
White, M. J. V., Ozkan, M., Medellin, J. E. G., Raczy, M. M., Koss, K. M., Solanki, A., Zhang, Z. J., Alpar, A. T., Naved, B. A., Wertheim, J. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-70737-4 · Cited by 11
Why Stress Matters: An Introduction
Tschumperlin, D. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_12 · Cited by 6
Self-citationShiraishi, M., Suzuki, K., & Yamaguchi, A. (2023) · The FASEB Journal · doi:10.1096/fj.202201899r · Cited by 7
RetractedTopical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis
Huda, M. N., Borrego, E. A., Guerena, C. D., Varela-Ramı́rez, A., Aguilera, R. J., Hamadani, C. M., Tanner, E. E. L., Badruddoza, A. Z. M., Agarwal, S. K., & Nurunnabi, M. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00039 · Cited by 6
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy
Hulo, P., Deshayes, S., Fresquet, J., Chené, A., Blandin, S., Boisgerault, N., Fonteneau, J., Treps, L., Denis, M. G., Bennouna, J., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02791-5 · Cited by 7
Xiang, Y., Zhang, L., Ye, J., Chen, Y., Ren, Q., Su, B., Xu, X., & Zhang, Q. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.03.011 · Cited by 8
The dynamics of cell–extracellular matrix interactions, with implications for tissue engineering
Petreaca, M. L., & Martins‐Green, M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00007-1 · Cited by 7
Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis
Bhatt, H. N., Diwan, R., Estevao, I. L., Dong, R., Smith, J., Xiao, C., Agarwal, S. K., & Nurunnabi, M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.04.029 · Cited by 5
Promoting apoptosis is key to reversing fibrosis
Collison, J. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.222 · Cited by 5
White, M. J. V., Ozkan, M., Medellin, J. E. G., Solanki, A., & Hubbell, J. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.07.447403 · Cited by 5
Farkas, L., Horowitz, J. C., & Mora, A. L. (2022) · European Respiratory Journal · doi:10.1183/13993003.01702-2022 · Cited by 5
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts
Merkt, W., Rodon, L., Deicher, F. S., Freitag, M., Claus, M., Lister, R. T., Han, H., Zhou, Y., Horne, A., Stütz, A. N., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adq5442 · Cited by 6
Self-citationWen, Y., Wu, J., Pu, Q., He, X., Wang, J., Feng, J., Zhang, Y., Si, F., Wen, J., & Yang, J.-H. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2194440 · Cited by 4
Fibroblasts in AKI: small army, big help
Zhu, S., Gui, Y., Liu, J.-J., Liu, S., & Zhou, D. F. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.05.012 · Cited by 4
Ring, N., Volpe, M. C., Stepišnik, T., Mamolo, M. G., Panov, P., Kocev, D., Vodret, S., Fortuna, S., Calabretti, A., Rehman, M., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04439-4 · Cited by 4
Mitochondrial physiology: An overview
Infantino, V., Todisco, S., & Convertini, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88462-4.00001-8 · Cited by 5
Esposito, G., Balzamino, B. O., Stigliano, E., Biamonte, F., Urbani, A., & Micera, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-81040-x · Cited by 4
Myofibroblast Functions in Tissue Repair and Fibrosis: An Introduction
Thannickal, V. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_2 · Cited by 4
Methods for Studying Myofibroblast Apoptotic Pathways
Zhou, Y., & Lagares, D. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_9 · Cited by 4
Self-citationRNA Sequencing Uncovers Antifibrotic Genes during Lung Fibrosis Resolution
Han, H., & Lagares, D. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0008ed · Cited by 4
Self-citationEmerging concepts and novel mechanisms in organ fibrosis
Ruiz‐Villalba, A., & Pardo–Saganta, A. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00446-7 · Cited by 5
Inhibition of Talin2 dedifferentiates myofibroblasts and reverses lung and kidney fibrosis
White, M. J. V., Ozkan, M., Medellin, J. E. G., Solanki, A., & Hubbell, J. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-00939-x · Cited by 7
Potential Efficacy of Proteasome Inhibitor, Delanzomib, for the Treatment of Renal Fibrosis
Sawa-Aihara, A., Hattori, K., Nagao, G., Yamada, Y., & Ishida, T. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00713 · Cited by 3
Ma, Q., Fan, Y., Cui, Y., Luo, Z., & Kang, H. (2024) · Biology · doi:10.3390/biology13040217 · Cited by 3
Mahmoudi, S., Mancini, E., Moore, A. L., Xu, L., Jahanbani, F., Hebestreit, K., Srinivasan, R., Li, X., Devarajan, K., Prélot, L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/448431 · Cited by 3
White, M. J. V., Ozkan, M., Medellin, J. E. G., Raczy, M. M., Koss, K. M., Solanki, A., Zhang, Z. J., Alpar, A. T., Naved, B. A., Wertheim, J. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.07.447405 · Cited by 3
Flaxman, H. A., Chrysovergi, M.-A., Han, H., Kabir, F., Lister, R. T., Chang, C., Black, K. E., Lagares, D., & Woo, C. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.09.531890 · Cited by 3
Self-citationEmerging Concepts in Therapeutic Interventions for Idiopathic Pulmonary Fibrosis
Schott, C. A., Mohning, M. P., & Cooley, J. C. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2651-1937 · Cited by 2
Davan-Wetton, C. S. A., Khodeneva, N., Denton, C. P., Abraham, D., Perretti, M., & Montero‐Melendez, T. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03635-3 · Cited by 2
Fertala, A. (2026) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-032-05273-5_11 · Cited by 2
Tu, X., Bach, T.-N., Baghela, A. S., Zielstorff, M., Smallridge, W., Chen, Q., Motlagh, S., Barr, T., Sze, M. A., Jang, I. S., et al. (2026) · Rheumatology · doi:10.1093/rheumatology/keag293 · Cited by 2
Naikawadi, R. P., & Wolters, P. J. (2021) · European Respiratory Journal · doi:10.1183/13993003.04500-2020 · Cited by 2
Small Molecules Accelerate Skin Wound Healing: Shikonin Efficacy and Mechanism of Action in Mice
Liu, J. X., Yang, L. F., Wan, Y., Zhao, W. E., & Li, S. (2024) · International Journal of Morphology · doi:10.4067/s0717-95022024000100127 · Cited by 2
Circadian clock regulation of myofibroblast fate
Tsoneva, Y., Velikova, T. V., & Nikolaev, G. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111774 · Cited by 1
Chen, C., Feng, Y., Ko, F. C. F., Lam, S. K., Yan, S., & Ho, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1597585 · Cited by 1
Li, M., Feng, Z., Zeng, S., Jin, M., Chen, S., Yang, H., & Huang, Y. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.04.055 · Cited by 2
Provoking myofibroblast death: Strategies to resolve fibrosis and remodel tumor microenvironment
Shalini, T., & Sudhandiran, G. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i12.111086 · Cited by 1
Cooley, J. C., Penick, S. K., Wilson, J. A., Javkhlan, N., Foster, D. G., Edelman, B., Schott, C. A., Humphries, S. M., Lynch, D. A., Schwartz, D. A., et al. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag045 · Cited by 1
Yang, L., Li, L., Mao, J., & Liang, Q. (2026) · British Journal of Dermatology · doi:10.1093/bjd/ljag258 · Cited by 1
Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers
Cai, G., Ren, J., Wang, L., Wu, Y., Wang, H., Cao, X., Shang, H., Hou, X., Wang, Y., Xue, H., et al. (2026) · MedComm · doi:10.1002/mco2.70827 · Cited by 2
Zhang, L., Li, M., Zhang, G., Wang, Z., & Qin, H. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103842 · Cited by 1
Metadata
- Authors
- Lagares, D., Santos, A., Grasberger, P. E., Liu, F., Probst, C. K., Rahimi, R. A., Sakai, N., Kuehl, T., Ryan, J., Bhola, P., Montero, J., Kapoor, M., Baron, M., Varelas, X., Tschumperlin, D. J., Letai, A., & Tager, A. M.
- Affiliations
- Harvard University (US)
- Fibrosis Research Center and Center for Immunology and Inflammatory Diseases, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- University Health Network (CA)
- Jewish General Hospital (CA)
- Boston University (US)
- Mayo Clinic (US)
- Corresponding author
- Lagares, David
- Santos, Alba
- Grasberger, Paula E.
- Tager, Andrew M.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-12-13
- Volume
- 9
- Issue
- 420
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC8520471
- OpenAlex
- W2774171294
- Cited by
- 246
- References
- 63
- Citations by year
- 2026: 31 · 2025: 25 · 2024: 30 · 2023: 36 · 2022: 21 · 2021: 34 · 2020: 28 · 2019: 23 · 2018: 17 · 2017: 1
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (2r01hl092961-13)
- National Heart, Lung, and Blood Institute (R01-HL-092961, R01HL108975, K08HL140173)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- navitoclax, BH3 mimetics, myofibroblast apoptosis, systemic sclerosis, skin fibrosis, fibrosis reversal, mitochondrial priming, BH3 profiling, anti-apoptotic proteins, drug response prediction
- MeSH terms
- Aniline Compounds, Animals, Biomechanical Phenomena, Cell Survival, Disease Models, Animal, Extracellular Matrix, Fibrosis, Humans, Male, Mice, Inbred C57BL, Mitochondria, Scleroderma, Systemic, Sulfonamides, Signal Transduction, Apoptosis, Dermis, Mechanotransduction, Cellular, bcl-X Protein, Mitochondrial Membranes, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review